China courier puts sick daughter in delivery box at work to save on childcare
The woman, surnamed Zhu, and her child were caught on camera by an online influencer in eastern China's Anhui province.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
18 hours ago
- The Star
Weight rebounds quickly after stopping anti-obesity jabs
GLP-1 receptor agonists, which form the recent popular weight-loss medications, make you feel full for longer, but the effect appears to wear off rather quickly once the drugs are stopped. — AFP Doctors around the world have been hailing recent 'miracle' medications that make weight loss far easier, but new research suggests that after a person stops taking some of these drugs, the weight tends to increase again rather quickly. People who received these medications lost significant weight during the therapy, and this even continued to a small extent for a few weeks after stopping the drugs, according to a research team led by Dr Wu Han and Dr Yang Wenjia from the Peking University People's Hospital in Beijing, China. However, from the eighth week after the end of therapy, the researchers said that there was a marked weight gain that persisted for many weeks. The extent of weight gain varies depending on the medication and lifestyle changes, according to the study, but there is a clear trend towards weight gain after stopping the drugs. This confirms existing findings, according to Association of Catholic Clinics chief physician for diabetology and West German Diabetes and Health Centre director Dr Stephan Martin in Dusseldorf, Germany. He said that some manufacturers of the medications had also demonstrated this themselves through randomised studies. Test subjects in the studies were given the active substances for 10 weeks, after which some were switched to a placebo. This group 'then continuously regained weight', Dr Martin reported. ALSO READ: Stop the drugs and regain the weight In the current study, the Chinese researchers also referred to an investigation in which people who had completed a 36-week treatment with the active substance tirzepatide (a GLP-1 receptor agonist) regained about half of the weight they had previously lost within a year of switching to a placebo. The newly-published meta-analysis summarised the results of 11 independent studies from around the world, including those on the drug orlistat, the combinations naltrexone/bupropion and phentermine/topiramate, as well as the group of GLP-1 receptor agonists. The data came from a total of 1,574 people in treatment groups and 893 in control groups. GLP-1 receptor agonists are included in the recent popular anti-obesity medications. In some countries, they are approved for type 2 diabetes and some cases of obesity, and they are known as lifestyle drugs for achieving a slim figure. These active substances, which are injected regularly, primarily prolong the time food stays in the digestive tract, thereby increasing the feeling of satiety. Side effects include gastrointestinal complaints. One aspect of the study stands out: Those who initially experienced significant weight loss during therapy tended to regain more weight afterwards, even if they participated in programmes to change their lifestyle, such as eating and exercise habits. 'This does not surprise me,' says professor of behavioural medicine Dr Anja Hilbert at Germany's Leipzig University Hospital. Similar experiences are seen, for example, in people who follow a very low-calorie diet – they also tend to regain more weight after the diet ends than those who undergo moderate calorie limits. However, Prof Hilbert noted that there were only a few participants for this aspect of the study. 'The results of the study actually suggest that long-term, perhaps even lifelong use of the medication may be necessary to stabilise weight,' she says. 'It is a long-term therapy,' Dr Martin emphasises. Anyone who believes they can lose weight with this therapy and then everything will be fine is mistaken. 'You need this therapy permanently,' he says. Some in the American healthcare system have raised concerns that many people may be unaware of this or may not accept it. According to studies, two-thirds of people treated for obesity – most of whom pay for the treatment themselves – stopped using the medication within a year. 'We don't know why: Maybe it becomes too expensive, maybe they have lost enough weight and believe it will now stay off,' says Dr Martin, who advocates for more overweight prevention rather than treating the consequences. – By Simone Andrea Mayer/dpa
The Star
a day ago
- The Star
More Bruneians stop smoking, engage in sports
FILE PHOTO: Chinese Wushu coach Lihui (back), who serves as the coach of the first-ever Brunei national Wushu team, guides a student at a stadium in Brunei capital city of Bandar Seri Begawan, on Nov. 16, 2018. The participation of Bruneians in physical activity has increased by 8.4 per cent compared to 2022-2024. - Xinhua BANDAR SERI BEGAWAN: More Bruneians have stopped smoking and are actively involved in sports, a government minister has said on Tuesday (Aug 5). Based on the latest findings of the National Health and Nutritional Status Survey 2022-2023, the smoking rate among the population has shown a decrease of 19.9 per cent to 13.4 per cent in adults, while the participation of the population in physical activity increased by 8.4 per cent, Minister of Health Md Isham Jaafar said at the legislative council. He said Brunei's Ministry of Health has outlined three national performance indicators, namely increased life expectancy, reduction in premature death rates due to non-communicable diseases, and community participation in health activities, for the implementation of Brunei Vision 2035. Priority has been given to the strengthening of health infrastructure and digital capabilities. He said the emphasis is on early prevention, regular screening, and more systematic chronic disease management. In addition, access to early screening services for major diseases such as cervical cancer and breast cancer has been enhanced. - Xinhua
New Straits Times
3 days ago
- New Straits Times
Nada: 50,000 undergoing rehab at home, 5,100 in Puspen centres
KOTA BARU: More than 50,000 people undergoing rehabilitation with the National Anti-Drug Agency (Nada) are currently receiving scheduled treatment while living with their families. Nada director-general Datuk Ruslin Jusoh said another 5,100 clients are receiving treatment at 28 Narcotics Addiction Rehabilitation Centres (Puspen) across the country. "There are currently 28 Puspen operating nationwide, housing over 5,000 clients undergoing rehabilitation. "Two other centres are not in operation at the moment as they are undergoing renovations," he told reporters after attending the state-level Kelantan Drug Eradication Action Council meeting here today. Ruslin said 98.2 per cent of Puspen trainees are Malays, while the rest are Chinese, Indian, and other ethnic groups. He added that 3.2 per cent of the clients are women, with the remainder being men. In Kelantan, he said that there are three rehabilitation centres located in Bachok, Jeli, and Kota Baru, housing nearly 500 trainees. Ruslin said Nada continues to encourage individuals struggling with drug addiction to seek treatment voluntarily. "Early treatment can lead to early recovery. "Even at the federal level, Youth and Sports Minister Hannah Yeoh is spearheading campaigns to encourage young people to come forward for treatment voluntarily," he said. He acknowledged that some drug users may be reluctant to seek help due to misinformation. "Some fear treatment because they've heard it takes up to two years, but that's not true. "If a person recovers quickly, we can release them earlier.
